Xylyx Bio Inc

Xylyx Bio Inc. is a company based in New York City, New York, specializing in biotechnology. The company employs 14 individuals and generates approximately $7 million in annual revenue. Xylyx Bio focuses on developing innovative solutions to address the critical issue of organ transplantation. Their core mission is to enhance the viability of donor organs initially deemed unsuitable for transplant, effectively reducing the number of patients awaiting life-saving procedures. This approach aims to significantly decrease transplant waiting list mortality and alleviate the substantial financial burden associated with organ transplantation. Xylyx Bio distinguishes itself through its commitment to cutting-edge research and development in organ rehabilitation. Their scientific expertise and dedication to improving patient outcomes position them as a leader in the field of transplantation medicine. For inquiries or further information, please visit Xylyx Bio's website at xylyxbio.com.